rawfin.tv
Teladoc Health Price Target Raised to $7.76, Implies 13% Downside
MarketsstocksAI Generated

Teladoc Health Price Target Raised to $7.76, Implies 13% Downside

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Analysts have increased the 12-month average price target for Teladoc Health, Inc. to $7.76 from $7.55. Despite the upward revision, the updated target suggests a 13% potential downside for the stock.

TDOCAnalyst RatingsHealthcare TechPrice TargetTelehealth

Related Articles

S&P 500 Heavyweights Face Earnings Test Amid Fed Meeting

S&P 500 Heavyweights Face Earnings Test Amid Fed Meeting

stocks
China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks